Bleomycin A5 (cas 11116-32-8) plus dexamethasone for control of growth in infantile parotid hemangiomas
-
Add time:07/21/2019 Source:sciencedirect.com
ObjectiveThe purpose of this study was to evaluate the efficacy of Bleomycin A5 (cas 11116-32-8) (pingyangmycin) plus dexamethasone for control of growth in infantile parotid hemangiomas.
We also recommend Trading Suppliers and Manufacturers of Bleomycin A5 (cas 11116-32-8). Pls Click Website Link as below: cas 11116-32-8 suppliers
Prev:Bleomycin A5 (cas 11116-32-8) sclerotherapy for cervicofacial lymphatic malformations
Next:Electrophoresis mobility shift assay and biosensor used in studying the interaction between Bleomycin A5 (cas 11116-32-8) and DNA) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma07/23/2019
- A clinical study of ultrasound-guided intralesional injection of Bleomycin A5 (cas 11116-32-8) on venous malformation in cervical-facial region in China07/22/2019
- Electrophoresis mobility shift assay and biosensor used in studying the interaction between Bleomycin A5 (cas 11116-32-8) and DNA07/20/2019
- Bleomycin A5 (cas 11116-32-8) sclerotherapy for cervicofacial lymphatic malformations07/19/2019
- How to use Bleomycin A5 (cas 11116-32-8) for infantile maxillofacial haemangiomas: Clinical evaluation of 82 consecutive cases07/18/2019
-
Health and Chemical more >